Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
Bagsværd, Denmark, 12 May 2025 – Novo Nordisk today presented data from the phase 3 REAL8 basket study, which showed that once-weekly Sogroya® (somapacitan) was non-inferior to the once-daily grow
Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial
06:06pm, Sunday, 11'th May 2025
Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial.
Novo Nordisk: It's Not Been This Cheap For Many Years
11:30am, Friday, 09'th May 2025
Novo Nordisk's stock has plummeted over 60%, while also arguably losing market share to Eli Lilly. Despite setbacks, Novo is actively enhancing market access for Wegovy and partnering with CVS and tel
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
07:22am, Friday, 09'th May 2025
Bagsværd, Denmark, 9 May 2025 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated person
Pressure is still on the pharma sector, says Mizuho's Jared Holz
07:23pm, Thursday, 08'th May 2025
Jared Holz, Mizuho, joins 'Fast Money' to talk headwinds to the pharma sector.
Hims & Hers Stock's 100% Surge Is Squeezing Shorts And It Might Just Be Getting Started
03:00pm, Thursday, 08'th May 2025
If short sellers were hoping for a flop from Hims & Hers Health Inc. HIMS, they may want to check their risk management settings. The telehealth disruptor dropped first-quarter earnings after the bell
Novo Nordisk (NVO) Upgraded to Buy: Here's What You Should Know
01:00pm, Thursday, 08'th May 2025
Novo Nordisk (NVO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
S&P 500 INDEX (SPX) Live: Markets Eye Potential Bullish Trend as Buying Resumes
01:00pm, Thursday, 08'th May 2025
Live Updates Live Coverage Has Ended Rates Unchanged, Stagflation Looms 2:20 pm by Gerelyn Terzo The Dow has reversed a deficit, turning a 200-point drop to a 27-point gain after the Federal Reserve k
Live Nasdaq Composite: Markets Rise on Fed Day Amid Trade Deal Hopes
01:00pm, Thursday, 08'th May 2025
Live Updates Live Coverage Has Ended GOOGL Falls 9% 2:51 pm by Gerelyn Terzo Google parent Alphabet (Nasdaq: GOOGL) stock is down a steep 9% to below $150 per share today after an Apple (Nasdaq; AAPL)
Novo Nordisk (NVO) is a Top Dividend Stock Right Now: Should You Buy?
12:45pm, Thursday, 08'th May 2025
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novo Nordisk (NVO) have what it takes?
Does Novo Nordisk (NVO) Have the Potential to Rally 51.24% as Wall Street Analysts Expect?
11:02am, Thursday, 08'th May 2025
The consensus price target hints at a 51.2% upside potential for Novo Nordisk (NVO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estim
Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers
08:41am, Thursday, 08'th May 2025
One day after WeightWatchers said that it would file for bankruptcy, weight-loss drug giant Novo Nordisk's outlook is brightening.
GLP-1 competition heats up: Novo Nordisk CEO talks Wegovy, CVS deal, earnings
02:30pm, Wednesday, 07'th May 2025
Pharmaceutical company Novo Nordisk (NVO) came out swinging Wednesday morning as the stock initially jumped on its first quarter earnings beat ($0.99 per share vs. estimates of $0.94).
Trump's trade war and inflation, Novo Nordisk CEO talks earnings
12:53pm, Wednesday, 07'th May 2025
Catalyst anchor Madison Mills breaks down the market moves for May 7, 2025. First, all eyes are on the Federal Reserve.
Novo Nordisk A/S (NVO) Q1 2025 Earnings Call Transcript
12:05pm, Wednesday, 07'th May 2025
Novo Nordisk A/S (NVO) Q1 2025 Results Conference Call May 7, 2025 7:00 AM ET Company Participants Jacob Rode - Head of Investor Relations Lars Jorgensen - President and Chief Executive Officer David
